Abstract
Objective: to identify nursing care for hematopoietic stem cell transplant recipients and their families. Methods: integrative review with searches in the databases SCOPUS; National Library of Medicine; Web of Science, Cumulative Index to Nursing and Allied Heath Literature and Latin American and Caribbean Literature in Health Sciences. The selected studies were published between 2008 and 2014. Results: 460 articles were initially identified, culminating in the final sample of seven studies analyzed in their entirety. Care provided varied in all studies, from actions directed to health education practices, to the accomplishment of complementary therapies and the implementation of Advanced Nursing Practice with a view to qualification of care. Conclusion: care provided includes health education actions, complementary therapies to promote well-being and quality of life, as well as the implementation of the Advanced Nursing Practice with a view to qualification of care.
Highlights
Hematopoietic stem cell transplantation is an aggressive therapeutic option for a set of genetically inherited or acquired onco-hematological and immunological diseases
Nursing care for hematopoietic stem cell transplant recipients and their families cal aspect, the following steps were performed: identification of the problem or research question; search in the literature, which included the definition of the inclusion and exclusion criteria of the articles; evaluation of data to define the information to be extracted from the selected articles; critical analysis of selected studies; and presentation of the review result[10]
A limitation of this study was the scarcity of articles on nursing care for hematopoietic stem cell transplant recipients and their relatives/caregivers, which may be associated with the use of only one crossing composed of three descriptors and which limited the retrieval of the articles researched
Summary
Hematopoietic stem cell transplantation is an aggressive therapeutic option for a set of genetically inherited or acquired onco-hematological and immunological diseases. Hematopoietic stem cell transplants are classified as autologous, when stem cells are from the patient him/herself; as allogeneic, when stem cells are from donors with compatible Human Histocompatibility Antigen, either they are related or not with the recipients; and syngeneic, when stem cells are from identical twin This procedure has the purpose of restoring the medullary and immunological function of patients affected by some onco-hematological or immunological impairment, with possibility of cure or increase of disease-free survival[3]. With increased survival after transplantation, the risk of developing late complications increases substantially, such as graft versus host disease, which causes dermatological, gastrointestinal, ophthalmologic and respiratory morbidities, among others These conditions may require different attention and care from the nursing team, the patient and their relatives and caregivers. These morbidities may impair quality of life or contribute to mortality of hematopoietic stem cell transplant recipients[4,5]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
